The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
SNWV · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
BLLN · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
INDV · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | SNWV | BLLN | GILD | INDV |
|---|---|---|---|---|
| Moat Score (0–100) | 71 | 72 (highest) | 71 | 70 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 75 | 85 (highest) | 70 | 78 |
| Pricing power | 87 | 59 | 99 | 100 (highest) |
| Returns on capital | — | — | 100 | — |
| Balance-sheet safety | 77 | 100 (highest) | 47 | 58 |
| Capital allocation | 44 (highest) | 44 (highest) | 39 | 43 |
| No price data | No price data | 88% above value if growth stopped today | No price data | |
| Market cap | $50.9M | $2.7B | $160.5B | $5.1B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |